发明名称 |
Calcium glutarate supplement and phosphorus binder |
摘要 |
Methods of controlling calcium intake and phosphate metabolism and metabolic acidosis in patients suffering from renal failure and associated hyperphosphatemia or patients predisposed to development of a hyperphosphatemic condition are provided. The method in accordance with this invention comprises administering to a patient a calcium glutarate compound. Therapeutic benefit can be realized in accordance with such method by administering the compound orally to a patient to increase available calcium and contact and bind with ingested phosphate in the patient's digestive tract, and thereby prevent its intestinal absorption.
|
申请公布号 |
US6887897(B2) |
申请公布日期 |
2005.05.03 |
申请号 |
US20010919025 |
申请日期 |
2001.07.31 |
申请人 |
MISSION PHARMACAL COMPANY |
发明人 |
WALSDORF, SR. NEILL B.;ALEXANDRIDES GEORGE |
分类号 |
A61K31/194;A61P3/12;(IPC1-7):A61K31/28 |
主分类号 |
A61K31/194 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|